샘플 요청 목록

 카트 문의
시장보고서
상품코드
2154174

무릎 연골 수복 시장

Knee Cartilage Repair
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 491 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,905,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,019,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,715,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 무릎 연골 수복 시장은 2032년까지 25억 달러에 달할 전망

2025년에 19억 달러로 추정되는 세계의 무릎 연골 수복 시장은 2025-2032년의 분석 기간에 CAGR 3.9%로 성장하며, 2032년까지 25억 달러에 달할 것으로 예상되고 있습니다. 이 리포트에서 분석 대상이 되고 있는 부문의 하나인 자가 연골 세포는 CAGR 3.2%를 기록하며, 분석 기간의 종료까지 9억 90만 달러에 달할 것으로 예상되고 있습니다. 동종 연골 세포 부문의 성장률은 분석 기간 중 CAGR 3.0%로 추정되고 있습니다.

미국 시장은 5억 1,190만 달러로 추계되는 한편, 중국은 CAGR 6.8%로 성장할 것으로 예측됩니다.

미국의 무릎 연골 수복 시장은 2025년에 5억 1,190만 달러로 추계되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025-2032년의 분석 기간에 CAGR 6.8%로 추이하며, 2032년까지 시장 규모가 5억 2,080만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다를 들 수 있으며, 분석 기간 중 각각 CAGR 1.6% 및 2.9%로 성장할 것으로 예측됩니다. 유럽내에서는 독일이 CAGR 약 2.2%로 성장할 것으로 예측됩니다.

세계의 무릎 연골 수복 시장 - 주요 동향과 촉진요인의 개요

새로운 수술 기술은 무릎 연골 복원 시장을 어떻게 변화시키고 있는가?

무릎 연골 재생 시장은 환자의 예후를 개선하고 회복 기간을 단축하는 새로운 수술 기술 및 최소 침습 수술의 개발에 힘입어 변혁의 한가운데에 있습니다. 마이크로프랙처 수술이나 자가 연골 세포 이식(ACI)과 같은 기존의 연골 재생 방법은 매트릭스 유도 자가 연골 세포 이식(MACI), 골연골 동종 이식, 그리고 줄기세포를 이용한 치료법과 같은 차세대 기술에 의해 더욱 진화하고 있습니다. 이러한 첨단 기술은 새로운 연골 조직의 통합을 촉진하고 수술 후 합병증 위험을 줄임으로써 연골 복원에 대해 더 효과적이고 지속가능한 해결책을 제공합니다. 저침습 치료 및 생물학적 치료에 대한 수요가 증가함에 따라 의료 종사자들은 이러한 혁신적인 기술을 점점 더 많이 채택하고 있으며, 이는 무릎 연골 재생 시장을 주도하고 있습니다.

왜 무릎 연골 재생 분야에서 생물학적·재생 의학에 대한 수요가 증가하고 있는가?

환자와 의료진이 연골 손상에 대해 보다 자연스럽고 장기적인 해결책을 추구함에 따라 무릎 연골 재생 분야에서 생물학적·재생 의학에 대한 수요가 증가하고 있습니다. 혈소판 농축 혈장(PRP), 중간엽 줄기세포(MSC) 치료, 성장인자를 이용한 치료 등의 생물학적 치료법은 치유를 촉진하고, 염증을 완화하며, 손상된 연골을 재생시킬 가능성을 지니고 있으며, 인기를 얻고 있습니다. 이러한 치료법은 신체 자체의 재생 능력을 활용하여 무릎 기능을 회복시킨다는 점에서 기존 치료법에 비해 큰 이점이 있습니다. 생물학적 치료의 이점에 대한 인식이 높아짐에 따라 임상 현장과 환자 모두에서 이러한 치료법으로의 전환이 진행되고 있으며, 이는 무릎 연골 재생 시장에 긍정적인 영향을 미치고 있습니다.

고령화 사회는 시장 성장을 촉진하는 데 있으며, 어떤 역할을 하고 있는가?

고령화는 무릎 연골 복원 시장의 성장을 이끄는 데 있으며, 매우 중요한 역할을 하고 있습니다. 전 세계 인구의 고령화에 따라 퇴행성 무릎 관절염이나 퇴행성 연골 손상 등 무릎 관련 질환의 발생률이 증가하고 있습니다. 고령자는 노화에 따른 변성으로 인해 연골이 마모되거나 손상되기 쉬우므로, 효과적이고 최소 침습적인 재생 솔루션에 대한 수요가 높아지고 있습니다. 또한 고령자들이 활동적인 생활을 지속하고 높은 삶의 질을 유지하려는 추세가 강해지고 있으며, 이는 첨단 연골 재생 시술에 대한 수요를 더욱 부추기고 있습니다. 이러한 인구 통계학적 변화는 무릎 연골 재생 제품 제조사 및 전문 외과수술 서비스를 제공하는 사업자에게 큰 시장 기회를 창출하고 있습니다.

무릎 연골 복원 시장의 성장은 어떤 요인에 의해 주도되고 있는가?

무릎 연골 재생 시장의 성장은 수술 기술의 발전, 생물학적 요법 및 재생 의학의 도입 확대, 그리고 고령화의 진행 등 여러 요인에 의해 주도되고 있습니다. MACI나 줄기세포 치료와 같은 혁신적인 치료법의 개발은 연골 재생의 유효성과 안전성을 높여 외과의사와 환자 모두를 매료시키고 있습니다. 자연 치유를 촉진하고 회복 기간을 단축하는 생물학적 치료에 대한 수요 증가도 시장 성장을 지원하고 있습니다. 또한 스포츠로 인한 부상 증가와 고령층의 관절 건강 유지에 대한 관심 증대도 무릎 연골 재생 솔루션에 대한 수요를 견인하고 있습니다. 의료 인프라 확충과 정형외과 분야의 연구개발 투자 확대 역시 시장의 견고한 성장 전망에 더욱 기여하고 있습니다.

부문:

세포원(자가 연골 세포원, 동종 연골 세포원, 중간엽줄기세포 근원, 무세포 생체 이식편원), 바이오소재(콜라겐계 바이오소재, 히알루론산/키토산계 바이오소재, 합성 폴리머계 바이오소재, 세라믹/복합재료계 바이오소재, 3D 바이오프린트 골연골 스캐폴드계 바이오소재), 용도(관절경 하 연골 형성술에 대한 응용, 마이크로 프랙션 차-에 대한 응용, 골연골 이식에 대한 응용, 자가 연골 세포 이식에 대한 응용, 세포를 이용한 연골 표면 재형성에 대한 응용, 기타 용도), 최종 용도(병원에서의 이용, 외래 수술 센터에서의 이용, 기타 최종 용도)

주요 기업

  • B. Braun SE
  • Histogenics Corporation
  • ISTO Biologics
  • Johnson &Johnson
  • Medipost Co., Ltd.
  • Osiris Therapeutics, Inc.
  • Smith &Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

해당 분야의 전문가 관점을 바탕으로 합니다.. 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착합니다. - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용합니다.-컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관지 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결합니다. - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있으며, 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공합니다. - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 상세히 검증합니다.

주요 지역의 시장 점유율을 면밀히 검토합니다. - 단일 글로벌 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구조는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞춰 상세도를 조정하여 주요 지역의 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 26.10.27

Global Knee Cartilage Repair Market to Reach US$2.5 Billion by 2032

The global market for Knee Cartilage Repair estimated at US$1.9 Billion in the year 2025, is expected to reach US$2.5 Billion by 2032, growing at a CAGR of 3.9% over the analysis period 2025-2032. Autologous Chondrocytes Cell Source, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$900.9 Million by the end of the analysis period. Growth in the Allogeneic Chondrocytes Cell Source segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$511.9 Million While China is Forecast to Grow at 6.8% CAGR

The Knee Cartilage Repair market in the U.S. is estimated at US$511.9 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$520.8 Million by the year 2032 trailing a CAGR of 6.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Knee Cartilage Repair Market - Key Trends & Drivers Summarized

How Are New Surgical Techniques Transforming the Knee Cartilage Repair Market?

The knee cartilage repair market is witnessing a transformation, driven by the development of new surgical techniques and minimally invasive procedures that improve patient outcomes and reduce recovery times. Traditional approaches to cartilage repair, such as microfracture surgery and autologous chondrocyte implantation (ACI), are being enhanced by next-generation techniques, including matrix-induced autologous chondrocyte implantation (MACI), osteochondral allograft transplantation, and stem cell-based therapies. These advanced techniques provide more effective and durable solutions for cartilage repair by promoting better integration of new cartilage tissue and reducing the risk of post-operative complications. As the demand for minimally invasive and biologic treatments grows, healthcare providers are increasingly adopting these innovative techniques, driving the market for knee cartilage repair.

Why Is There an Increasing Demand for Biologic and Regenerative Therapies in Knee Cartilage Repair?

The demand for biologic and regenerative therapies in knee cartilage repair is on the rise as patients and healthcare providers seek more natural and long-lasting solutions for cartilage injuries. Biologic therapies, such as platelet-rich plasma (PRP), mesenchymal stem cell (MSC) therapy, and growth factor-based treatments, are gaining popularity due to their potential to accelerate healing, reduce inflammation, and regenerate damaged cartilage. These therapies offer significant advantages over traditional approaches by utilizing the body’s own regenerative capabilities to restore knee function. As awareness about the benefits of biologic treatments grows, there is an increasing shift towards these therapies in both clinical practice and patient preference, which is positively impacting the knee cartilage repair market.

What Role Does an Aging Population Play in Driving Market Growth?

An aging population is playing a critical role in driving the growth of the knee cartilage repair market. As the global population ages, the incidence of knee-related conditions, such as osteoarthritis and degenerative cartilage injuries, is increasing. Older adults are more susceptible to cartilage wear and tear due to age-related degeneration, leading to a growing demand for effective and minimally invasive repair solutions. Moreover, there is a rising trend among aging individuals to remain active and maintain a high quality of life, which further drives the demand for advanced cartilage repair procedures. This demographic shift is creating a significant market opportunity for manufacturers of knee cartilage repair products and providers of specialized surgical services.

How Is the Growth in the Knee Cartilage Repair Market Driven by Several Factors?

The growth in the knee cartilage repair market is driven by several factors, including advancements in surgical techniques, increasing adoption of biologic and regenerative therapies, and a growing aging population. The development of innovative procedures, such as MACI and stem cell therapies, is enhancing the effectiveness and safety of cartilage repair, attracting both surgeons and patients. The rising demand for biologic treatments that offer natural healing and reduced recovery times is also fueling market growth. Additionally, the increase in sports-related injuries and a greater emphasis on maintaining joint health among older adults are driving demand for knee cartilage repair solutions. The expansion of healthcare infrastructure and growing investment in orthopedic research and development are further contributing to the market's robust growth outlook.

SCOPE OF STUDY:

The report analyzes the Knee Cartilage Repair market by the following Segments, and Geographic Regions/Countries:

Segments:

Cell Source (Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source, Acellular Biologic Grafts Cell Source); Biomaterial (Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial, 3-D Bioprinted Osteochondral Scaffolds Biomaterial); Application (Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • B. Braun SE
  • Histogenics Corporation
  • ISTO Biologics
  • Johnson & Johnson
  • Medipost Co., Ltd.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Knee Cartilage Repair - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidences of Sports Injuries and Osteoarthritis Boosting Market Demand
    • Increasing Adoption of Minimally Invasive Surgical Techniques for Cartilage Repair
    • Growth in Geriatric Population Driving Demand for Knee Cartilage Replacement
    • Advancements in Regenerative Medicine and Stem Cell Therapies Enhancing Treatment Options
    • Expanding Use of Biomaterials in Cartilage Repair for Improved Patient Outcomes
    • Development of 3D Printing Technologies for Custom Knee Implants
    • Increasing Adoption of Hyaluronic Acid Injections as Non-Surgical Solutions
    • Surge in Clinical Trials and Research Activities Advancing Market Innovations
    • Growing Awareness and Availability of Advanced Cartilage Repair Techniques
    • Favorable Reimbursement Policies and Regulatory Approvals Driving Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 4: World Knee Cartilage Repair Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Knee Cartilage Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Knee Cartilage Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Knee Cartilage Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Autologous Chondrocytes Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Autologous Chondrocytes Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Autologous Chondrocytes Cell Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Allogeneic Chondrocytes Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Allogeneic Chondrocytes Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Allogeneic Chondrocytes Cell Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Mesenchymal Stem Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Mesenchymal Stem Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Mesenchymal Stem Cell Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Acellular Biologic Grafts Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Acellular Biologic Grafts Cell Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Acellular Biologic Grafts Cell Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Collagen-based Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Collagen-based Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Collagen-based Biomaterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Hyaluronic-Acid / Chitosan Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Hyaluronic-Acid / Chitosan Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Hyaluronic-Acid / Chitosan Biomaterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Synthetic Polymer Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Synthetic Polymer Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Synthetic Polymer Biomaterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Ceramic / Composite Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Ceramic / Composite Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Ceramic / Composite Biomaterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for 3-D Bioprinted Osteochondral Scaffolds Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for 3-D Bioprinted Osteochondral Scaffolds Biomaterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for 3-D Bioprinted Osteochondral Scaffolds Biomaterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Arthroscopic Chondroplasty Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Arthroscopic Chondroplasty Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Arthroscopic Chondroplasty Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for Microfracture Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for Microfracture Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for Microfracture Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 41: World Recent Past, Current & Future Analysis for Osteochondral Graft Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 42: World Historic Review for Osteochondral Graft Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 43: World 13-Year Perspective for Osteochondral Graft Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 44: World Recent Past, Current & Future Analysis for Autologous Chondrocyte Implantation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 45: World Historic Review for Autologous Chondrocyte Implantation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 46: World 13-Year Perspective for Autologous Chondrocyte Implantation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 47: World Recent Past, Current & Future Analysis for Cell-based Cartilage Resurfacing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 48: World Historic Review for Cell-based Cartilage Resurfacing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 49: World 13-Year Perspective for Cell-based Cartilage Resurfacing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 50: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 51: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 52: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 53: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 54: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 55: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 56: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 57: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 58: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 59: USA Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 60: USA Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 61: USA 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 62: USA Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 63: USA Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 64: USA 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 65: USA Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 66: USA Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 67: USA 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 68: USA Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 69: USA Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 70: USA 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Canada Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 73: Canada 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Canada Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 76: Canada 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 78: Canada Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 79: Canada 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Canada Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 82: Canada 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • JAPAN
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Japan Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 85: Japan 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Japan Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 88: Japan 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Japan Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 91: Japan 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Japan Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 94: Japan 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CHINA
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 95: China Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 96: China Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 97: China 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 98: China Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 99: China Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 100: China 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 101: China Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 102: China Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 103: China 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 104: China Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 105: China Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 106: China 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • EUROPE
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Europe Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 109: Europe 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 111: Europe Historic Review for Knee Cartilage Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 112: Europe 13-Year Perspective for Knee Cartilage Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Europe Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 115: Europe 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Europe Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 118: Europe 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Europe Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 121: Europe 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • FRANCE
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 122: France Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 123: France Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 124: France 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 125: France Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 126: France Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 127: France 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 128: France Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 129: France Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 130: France 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 131: France Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 132: France Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 133: France 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • GERMANY
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Germany Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 136: Germany 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Germany Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 139: Germany 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Germany Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 142: Germany 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Germany Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 145: Germany 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Italy Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 148: Italy 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Italy Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 151: Italy 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Italy Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 154: Italy 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Italy Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 157: Italy 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 158: UK Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 159: UK Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 160: UK 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 161: UK Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 162: UK Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 163: UK 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 164: UK Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 165: UK Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 166: UK 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 167: UK Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 168: UK Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 169: UK 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Spain Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 172: Spain 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Spain Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 175: Spain 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Spain Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 178: Spain 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Spain Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 181: Spain 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Russia Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 184: Russia 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Russia Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 187: Russia 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Russia Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 190: Russia 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Russia Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 193: Russia 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 196: Rest of Europe 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 199: Rest of Europe 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 202: Rest of Europe 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 205: Rest of Europe 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Knee Cartilage Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 208: Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 211: Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 214: Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 217: Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 220: Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Australia Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 223: Australia 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Australia Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 226: Australia 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Australia Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 229: Australia 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Australia Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 232: Australia 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • INDIA
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 233: India Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 234: India Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 235: India 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 236: India Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 237: India Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 238: India 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 239: India Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 240: India Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 241: India 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 242: India Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 243: India Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 244: India 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 246: South Korea Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 247: South Korea 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 249: South Korea Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 250: South Korea 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 252: South Korea Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 253: South Korea 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 255: South Korea Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 256: South Korea 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Latin America Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 271: Latin America 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 273: Latin America Historic Review for Knee Cartilage Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 274: Latin America 13-Year Perspective for Knee Cartilage Repair by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Latin America Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 277: Latin America 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Latin America Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 280: Latin America 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Latin America Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 283: Latin America 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Argentina Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 286: Argentina 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Argentina Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 289: Argentina 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Argentina Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 292: Argentina 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Argentina Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 295: Argentina 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Brazil Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 298: Brazil 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Brazil Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 301: Brazil 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Brazil Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 304: Brazil 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Brazil Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 307: Brazil 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Mexico Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 310: Mexico 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 312: Mexico Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 313: Mexico 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 315: Mexico Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 316: Mexico 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 318: Mexico Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 319: Mexico 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 322: Rest of Latin America 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 325: Rest of Latin America 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 328: Rest of Latin America 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 331: Rest of Latin America 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 333: Middle East Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 334: Middle East 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 336: Middle East Historic Review for Knee Cartilage Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 337: Middle East 13-Year Perspective for Knee Cartilage Repair by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 339: Middle East Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 340: Middle East 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 342: Middle East Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 343: Middle East 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 345: Middle East Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 346: Middle East 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 348: Iran Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 349: Iran 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 351: Iran Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 352: Iran 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 354: Iran Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 355: Iran 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 357: Iran Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 358: Iran 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 360: Israel Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 361: Israel 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 363: Israel Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 364: Israel 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 366: Israel Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 367: Israel 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 369: Israel Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 370: Israel 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 373: Saudi Arabia 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 376: Saudi Arabia 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 379: Saudi Arabia 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 382: Saudi Arabia 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 384: UAE Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 385: UAE 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 387: UAE Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 388: UAE 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 390: UAE Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 391: UAE 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 393: UAE Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 394: UAE 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 397: Rest of Middle East 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 400: Rest of Middle East 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 403: Rest of Middle East 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 406: Rest of Middle East 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AFRICA
    • Knee Cartilage Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 408: Africa Historic Review for Knee Cartilage Repair by Application - Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 409: Africa 13-Year Perspective for Knee Cartilage Repair by Application - Percentage Breakdown of Value Sales for Arthroscopic Chondroplasty Application, Microfracture Application, Osteochondral Graft Application, Autologous Chondrocyte Implantation Application, Cell-based Cartilage Resurfacing Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 411: Africa Historic Review for Knee Cartilage Repair by Cell Source - Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 412: Africa 13-Year Perspective for Knee Cartilage Repair by Cell Source - Percentage Breakdown of Value Sales for Autologous Chondrocytes Cell Source, Allogeneic Chondrocytes Cell Source, Mesenchymal Stem Cell Source and Acellular Biologic Grafts Cell Source for the Years 2020, 2026 & 2032
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 414: Africa Historic Review for Knee Cartilage Repair by Biomaterial - Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 415: Africa 13-Year Perspective for Knee Cartilage Repair by Biomaterial - Percentage Breakdown of Value Sales for Collagen-based Biomaterial, Hyaluronic-Acid / Chitosan Biomaterial, Synthetic Polymer Biomaterial, Ceramic / Composite Biomaterial and 3-D Bioprinted Osteochondral Scaffolds Biomaterial for the Years 2020, 2026 & 2032
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 417: Africa Historic Review for Knee Cartilage Repair by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 418: Africa 13-Year Perspective for Knee Cartilage Repair by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기